Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines. [electronic resource]
Producer: 20150120Description: e92378 p. digitalISSN:- 1932-6203
- Animals
- Boronic Acids -- pharmacology
- Bortezomib
- Cell Line, Tumor
- DNA Copy Number Variations
- Doxorubicin -- pharmacology
- Heterografts
- Humans
- Immunophenotyping
- Melphalan -- pharmacology
- Mice, SCID
- Multiple Myeloma -- immunology
- Neoplastic Stem Cells
- Phenotype
- Plasma Cells -- immunology
- Precursor Cells, B-Lymphoid
- Pyrazines -- pharmacology
- Syndecan-1 -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.